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Abstract 
 
Doxorubicin, primary chemoteurapeutic agent used for breast cancer treatment, is 
known to have various side effects included multi drug resistance (MDR) phenomenon. 
Therefore, exploration of co-chemotherapeutic agent is important to be conducted in order 
to prevent MDR. Secang (Caesalpinia sappan L.) which contains active compounds brazilin and 
brazilein, is proven to have activity as anticancer. The aim of this study is to determine the 
potency of Caesalpinia sappan L. ethanolic extract (CEE) as co-chemotherapeutic agent of 
doxorubicin and its mechanism through apoptosis induction on T47D breast cancer cells. 
Caesalpinia sappan L. heartwood powder was macerated with ethanol 70%. The cytotoxic 
effect of CEE alone and its combination with doxorubicin was analyzed using MTT assay. 
Apoptosis assay was done by flowcytometry-annexin V method. CEE showed cytotoxic 
activity on T47D cells with IC50 value of 35 µg/ml, while combinatorial test showed that all of 
combination doses of CEE and doxorubicin gave synergistic effect. Flowcytometry-annexin V 
assay proved that treatment of CEE induced apoptosis of doxorubicin. Based on these results, 
we conclude that Caesalpinia sappan L. heartwood ethanolic extract is potential to be 
developed as co-chemotherapeutic agent of doxorubicin. 
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INTRODUCTION 
 
Breast cancer is the most frequently 
diagnosed cancer and the leading cause of death 
in women (Fang et al., 2011). Sistem Informasi 
Rumah Sakit (SIRS)/Hospital Information 
System mentions that breast cancer ranks first 
in hospitalized patients in all hospitals in 
Indonesia (16.85%) (Dinkes, 2010). Breast 
cancer shows complex pathological 
mechanisms, structural changes at the 
molecular level to determine various aspects 
that affect the nature of the disease (Dong, 
2006). Malignant nature of cancer, a major 
challenge in the clinical world, primarily 
because it has the ability to independently 
provide sufficient signal growth, inhibits anti-
growth signals, capable invaded other tissues 
and metastasis, has potency to divide in an 
unlimited amount, capable to form new blood 
vessels (angiogenesis), and has a mechanism of 
evasion of apoptosis (programmed cell death) 
that causes cancer cells to be able to proliferate 
rapidly (Hanahan and Weinberg, 2011). 
Mechanisms in cancer cells avoid apoptosis has 
become a serious attention in the clinical world, 
and influenced researcher to aim at developing 
drugs that can induce apoptosis in cancer cells 
(Wong, 2011). 
Primary treatment of breast cancer is 
done with chemotherapy if surgery is not able 
to cope with cancer that has metastasis. 
Chemotherapy is a treatment step with a 
chemical substance that showed cytotoxic 
activity and work directly on cancer cells 
(Staerk et al., 2002). 
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Doxorubicin is one of many 
chemotherapeutic agents used in cancer 
treatment, works by inhibiting the cell cycle at 
the G2/M phase by inducing DNA damage 
(Potter et al., 2002). However, long term used 
of doxorubicin caused adverse side effects, such 
as heart problems, nausea, diarrhea, alopecia 
(Gunawan, 2007) and resistance (Lee, 2010). 
Dose reduction is done to reduce the side 
effects of doxorubicin (Wattanapitayakul et al., 
2005), but it may also reduce its efficacy 
against cancer cells. Therefore, it is necessary 
to explore a co-chemotherapy agent which 
combined with doxorubicin to improve 
doxorubicin efficacy with lower toxicity to 
normal tissue. 
Secang (Caesalpinia sappan L.) is one of 
the plants potential to be developed as a co-
chemotherapeutic agent with doxorubicin. 
Empirically, secang’s heartwood used as the 
main ingredient in Indonesian traditional 
beverage such as wedang secang and wedang 
uwuh. Pharmacologically, it was reported that 
secang induces cell death in neck cancer and 
this effect is associated with the increase of p53 
and p21
WAF1/CIP1 
protein expression at the 
cellular level (Kim et al., 2005). Secang also 
induces apoptosis in several cancer cell types 
such as human promyelocytic leukemia HL-60 
cells (Zhang et al., 2002), and human leukemia 
K562 cells (Wang et al., 2001). The scientific 
evidence indicates that secang is potential to be 
developed as a co-chemotherapeutic agent with 
doxorubicin. 
This study was conducted in a series of 
tests to determine the effect of Secang 
(Caesalpinia sappan L.) heartwood ethanolic 
extract alone and its combination with 
doxorubicin in increasing cytotoxic activity and 
apoptosis induction of doxorubicin on T47D 
breast cancer cells. Scientific data obtained 
from this research can be used as the basic of 
the application of the Caesalpinia sappan L. 
heartwood ethanolic extract in the treatment of 
breast cancer. 
 
MATERIALS AND METHODS 
 
Sample Preparation  
Dried Caesalpinia sappan L. shavings 
heartwood were obtain from Wonosari 
Yogyakarta, Indonesia. The heartwood then 
powdered and standardized by Laboratory of 
Biology, Faculty of Pharmacy Universitas 
Gadjah Mada. Dried powder was then 
macerated for 5 days with 70% ethanol. Filtrate 
was collected then concentrated using rotary 
evaporator (Heidolph WB2000). For 
application on cells, Caesalpinia sappan L. 
ethanolic extract (CEE) was dissolved in 
dimethyl sulfoxide as co-solvent with 
concentration 5 mg/ml, and then diluted in 
DMEM cell culture medium in various 
concentrations. 
 
Cells Culture 
Human breast cancer T47D culture 
cells were a collection of Cancer 
Chemoprevention Research Center (CCRC), 
Universitas Gadjah Mada. The cell line was 
kindly given by Prof. Kawaichi, Nara Institute 
of Science and Technology (NAIST), Japan. 
 
Chemicals 
Making 100 ml cell culture medium 
was prepared by mix Dulbecco’s Modified 
Eagle Medium (DMEM) (Gibco) medium stock 
contain HEPES (Sigma) and sodium 
bicarbonate (Sigma), 10% v/v Fetal Bovine 
Serum (FBS) (Gibco), 1% Penicillin-
Streptomycin (Gibco), and 0,5% Fungizone 
(Gibco). Tripsin-EDTA 0,25% (Gibco) were 
used for cell preparation. For cytotoxicity assay, 
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 
diphenyl tetrazolium bromide) reagent were 
used which was dissolved in PBS with 
concentration 5 mg/ml. Phosphate Buffer Saline 
(PBS) pH 7.4 containing KCl (HPLC grade, 
Sigma), NaCl (HPLC grade, Sigma), Na2HPO4 
(HPLC grade, Sigma), and KH2PO4 (HPLC 
grade, Sigma) dissolved in aquadest as washing 
reagent and 10% b/v Sodium Dodecyl Sulphate 
(SDS) (Merck) dissolved in 0.01 N HCl 
(Merck) as stopper reagent. Annexin-FITC was 
diluted in binding buffer (10mM HEPES, 100 
mM NaCl, 10 mM KCl, 1 mM MgCl2, 1.8 mM 
CaCl2) which is contained propidium iodide (50 
µg/ml). 
 
Cytotoxic Assay 
T47D cells were planted in 96-well 
plates (Iwaki) with 5x10
3
 cells/well and divided 
into control and treatment group. Final 
concentrations of CEE that treaten to cells were 
10, 25, 50, 100, and 150 µg/mL For 
combinatorial assay, final concentrations of 
CEE were 
1
/8, 
1
/4, 
2
/5,
 1
/2  IC50 and doxorubicin 
were 
1
/10,
 2
/10, 
3
/10, 
4
/10 IC50. Based on Fitriasari 
et al. (2009) doxorubicin has IC50 value of 15 
nM on T47D cells. After 24 h of incubation, 
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culture medium was removed and cells were 
washed using PBS (Sigma). 5 mg/mL of MTT 
(3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl 
tetrazolium bromide) on PBS (Sigma) was  
diluted by DMEM culture medium (1:10) and 
100 µl of it was added into each well. After 
incubated for 3-4 h the reaction was stopped by 
Sodium Dodecyl Sulfate (SDS) 10% in HCL 
0,01 N. After that, the plate was incubated for 
one night in room condition at dark place. To 
make sure the formazan was dissolved, the 
plate was shaked for 10 minutes and the 
absorbance was then measured using ELISA 
reader at wave length of 595 nm.  
 
Apoptosis Assay 
Cells (5x10
5
 cells/well) were transferred 
in to six well tissue culture plate (Iwaki) and 
incubated for 24 h. Cells were treated with CEE, 
doxorubicin, and their combination with 
concentration ½ IC50 and then incubated for 24 
h. After incubation, adherent and detached cells 
were collected and centrifugated at 2000 rpm 
for 3 min, then washed twice with cold PBS.  
Cells were resuspended in 500 µl of Annexin V 
buffer (Biovision) and then treated with 
annexin V and propidium iodide for 10 min at 
37
o
C. The treated cells were then subjected to 
FACS flowcytometry. Bivariant analysis of 
FITC-fluoresence (FL-1) and PI-fluoresence 
(FL-3) gave different cell populations where 
FITC (-) and PI (-) were designated as viable 
cells; FITC (+) and PI (-) phenotype as 
apoptotic cells; FITC (-) and PI (+) as necrotic 
cells; and FITC (+) and PI (+) as late apoptotic 
cells. 
 
Data Analysis 
Single cytotoxicity assay. To determine 
cell viability, percent viability was calculated as 
[(absorbance of treated-drug) - (absorbance of 
medium)/ (absorbance of control (untreated) 
cells - absorbance of medium)] × 100%. Linier 
regression between log concentration and % 
cell viability giving the equation Y = Bx + A 
were used to calculate IC50 value. The IC50 
values are defined as the drug concentrations 
required to reduce the absorbance by 50% of 
the control.  
Combinatorial cytotoxic assay. 
Combinatorial treatment was evaluated by 
calculating Combination Index (CI) value and 
interpretation was done based on Reynolds and 
Maurer (2005), which has the formula as 
follows. 
 
CI = 
   
   
 + 
   
   
 + 
      
      
 
 
 
RESULTS AND DISCUSSION 
  
In order to determine cytotoxic effect of 
CEE on T47D cells, MTT assay was done with 
various concentrations of CEE treatments. As 
shown in Fig. 1, T47D cells viability was 
decreased after CEE treatment for 24 h in dose 
dependent manner. The MTT results 
demonstrated that CEE has potent cytotoxicity 
against T47D with IC50 value of 35 µg/ml. 
 
 
Figure 1. Cytotoxic effect of CEE on T47D cells. T47D cells (5000 cells/well) were seeded in 96 
wellplate and treated with CEE 10, 25, 50, 100, and 150 µg/mL. Plate was then incubated 
for 24 hours and cells viability was determined by using MTT assay as described in methods. 
The higher concentration of CEE caused lower cells viability. Data were mean of two 
replications  ̅      (p<0,05). IC50 value was calculated using linier regression and CEE 
perform cytotoxicity with IC50 value of 35 µg/ml. 
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Moreover, the present study observed 
potency of CEE increase doxorubicin’s 
cytotoxicity. Cell morphology after treatment 
was observed (Fig. 2(A)-2(D)). Treatment of 
CEE and doxorubicin alone led to cells’ 
morphological changing, (Fig. 2(B) and 2(C)) 
compared to control cells (2A). Combination of 
them caused more changes compared to single 
treated cells (Fig. 2(D)). Combination of CEE 
and doxorubicin with various concentrations 
reduced percent cells viability as shown in Fig. 
2(E). Combination treatment of CEE and 
doxorubicin on T47D cells gave synergistic 
effect in all concentration that tested with CI 
values less than 0.9, shown in Table I. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Combinational cytotoxic effect of CEE and doxorubicin on T47D cells. T47D cells (5000 
cells/well) were seeded in 96 wellplate and treated with CEE 1/8, 1/4, 2/5,  1/2  IC50 and 
doxorubicin 1/10, 2/10, 3/10, 4/10 IC50. Plate was then incubated for 24 hours and cells viability 
was determined by using MTT assay as described in methods. Combinational treatment 
altered cells morphology. Cells treated with (A) control cells, (B) CEE, (C) doxorubicin, 
and (D) combination of CEE and doxorubicin. White arrows (       ) showed viable cells 
while black arrows (         ) showed death cells were observed under light microscope with 
400x magnification. Graph (E) showed that combination of CEE and doxorubicin decreased 
cells viability compared to doxorubicin solely.  
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Table I. Combination Index of Combination of CEE and Doxorubicin  
CEE 
(µg/ml) 
Dox (nM) 
1,5 3 4,5 6 
4,5 3,9 x 10-2 3,1 x 10-2 4,6 x 10-2 6,4 x 10-2 
9 3,7 x 10-2 4,7 x 10-4 5,2 x 10-4 6,4 x 10-4 
13,5 9,0 x 10-2 5,3 x 10-4 8,7 x 10-6 8,4 x 10-6 
18 1,5 x 10-1 1,3 x 10-3 8,7 x 10-6 2,0 x 10-7 
  
 
Synergistic effect caused by 
combinational treatment of CEE and 
doxorubicin could be related with apoptosis 
and/or cell cycle arrest. To evaluate the impact 
of CEE and doxorubicin induce apoptosis on 
T47D cells, apoptosis phenomenon were 
detected using flowcytometric. This method is 
detected translocation of phosphatidyl serine 
residues which are normally located in the 
internal phospholipid layer to external layer in 
apoptotic cells. The result showed that 
combination of doxorubicin with CEE induced 
apoptosis rates of late apoptotic cells, but did 
not induced early apoptotic cells on T47D cells 
(Fig. 3). The percentage of late apoptotic cells 
were increased after treatment with CEE alone 
(25.80%) or its combination with doxorubicin 
(39.88 %) in comparison to the control cells and 
doxorubicin treated cells (1.12 % and 1.27 %, 
respectively). While treatment of CEE alone led 
to increase early apoptotic cells compare with 
control or doxorubicin treated cells (29.86 %; 
2.82 %; and 16 %, respectively). However, 
treatment of CEE alone gave unsignificant 
differences percentage of apoptotic cells 
compare with CEE combination with 
doxorubicin (55.67 % and 54.55 %, 
respectively). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Effect of CEE-doxorubicin on T47D cells apoptosis. T47D cells were seeded at 5x105 
cells/well on six wells tissue culture plate, then treated with CEE ½ IC50 alone and its 
combination with doxorubicin ½ IC50. After 24 hours of incubation, cells were harvested as 
described in methods, added with AnnexinV and PI reagent, then subjected to FACS 
flowcytometry. Flowcytometric profile of cells treated with (A) control, (B) CEE, (C) 
doxorubicin, and (D) combination of CEE and doxorubicin. There are 4 quadrans: lower 
left (LL) indicates viable cells, lower right (LR) indicating early apoptotic cells, upper left 
(UL) indicating late apoptotic cell, upper right (UR) indicating necrotic cells. Graph (E) 
showed that combination of CEE and doxorubicin induced apoptosis. 
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Doxorubicin is the most widely used 
drug in the treatment of various human 
neoplasms, espessially breast cancer. However, 
long term use of doxorubicin causes several 
side effects such as cardiotoxicity and multi 
drug resistance, that leading to cause cancer 
treatment failure. Many of cancer patients 
would seek other complementary or alternative 
medicines. Indonesia, as a country which has 
large biodiversity, has become one of the 
sources of herbal product that used for cancer 
treatment. However, very little of them is 
known about their action and possible 
interaction with other anticancer drugs. Thus, 
exploration about medicinal plant’s activity on 
cancer cells is helpful as basic of their used. 
Caesalpinia sappan L. has been used as 
traditional medicine in various countries 
including Indonesia. The results of current 
study demonstrated potentially ability of CEE 
on inhibiting T47D cells proliferation with IC50 
value of 35 μg/ml in dose dependent manner. 
While, when combine with doxorubicin, CEE 
could increase cytotoxic effects of doxorubicin 
in all tested concentration. This indicates that 
CEE might perform dominant effect on 
combination compared to doxorubicin.  
Combination therapy is a rationale strategy to 
increase response and tolerability and to 
decrease resistance. This result indicates that 
CEE has a potency to be developed as co-
chemotherapeutic agent for doxorubicin in 
breast cancer. 
Mechanism that mediates cytotoxic 
activity of CEE on T47D cells can be 
undergoes by apoptosis and or cell cycle arrest. 
Kim et al. (2005) reported that Caesalpinia 
sappan was able to induce expression of p53 
and p21
WAF1/CIP1
 at cellular level. Caesalpinia 
sappan has been reported to induce apoptosis in 
several cancer cell types such as human 
promyelocytic leukemia HL-60 cells (Zhang et 
al., 2002), and human leukemia K562 cells 
(Wang et al., 2001). Nurulita and Muflih (2006) 
reported that secang’s methanolic extract has 
cytotoxic effect on T47D cells with IC50 value 
of 150.9 µg/ml, and observations on the 
morphology of cells after double staining 
method with ethidium bromide-acridyn orange 
showed apoptosis phenomenon. The ability to 
induce apoptosis in cancer cells is an important 
property of a candidate anticancer drug because 
cancer cells are capable to evading apoptosis.  
The major finding of the present study is 
an effect of CEE in inducing apoptosis of 
doxorubicin on T47D cells. Human breast 
cancer T47D cells are ER/PR-positive cells that 
express wildtype caspase-3, wildtype caspase-7, 
and mutant p53 (Bouker et al., 2005; Schafer et 
al., 2000). Mutations in  p53 gene lead to 
inhibition of doxorubicin induced apoptosis in 
T47D cells. Mechanisms that mediate 
doxorubicin induced apoptosis in T47D cells 
only through extrinsic pathway by tumor 
necrosis factor (TNF), so induction of apoptosis 
is less effective (Keane et al., 1999). Our study 
represented that CEE induced apoptosis on 
T47D cells while treatment alone or 
combination with doxorubicin compare with 
control and treatment of doxorubicin alone. 
However, compare with the combination 
treatment, administration of CEE alone exhibit 
no differences percentage of apoptotic cells of 
T47D cells. This result indicates that CEE 
might has stronger effect than doxorubicin on 
T47D cells.  
Various studies about C. sappan’s active 
compound have been reported on its anticancer 
activity. Brazilein, a flavonoid compound of 
Caesalpinia sappan has been known to cause 
down-regulation of survivin, and increase 
activation of caspase-9 and caspase-3 and 
induce PARP (Poly ADP ribose polymerase) 
cleavage in HepG2 liver cancer cells (Zhong et 
al., 2009). Tao et al. (2011) reported that 
brazilein is able to improve the sensitivity of 
K562 and K562/AO2 leukemia cells resistant to 
doxorubicin chemotherapeutic agents, because 
brazilein is not a substrate of P-gp protein. 
Previous study by Ren et al. (2011) mentioned 
that brazilin, another compound of Caesalpinia 
sappan, induced apoptosis of T24 bladder 
cancer cells, but the mechanisms of this activity 
not fully understand. These mechanisms might 
be responsible in apoptosis induction of 
Caesalpinia sappan in T47D cells. Thus, 
further study is needed to be conducted. 
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